Cardlytics (CDLX) Equity Average (2017 - 2025)
Cardlytics (CDLX) has disclosed Equity Average for 9 consecutive years, with -$5.6 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Average fell 108.03% year-over-year to -$5.6 million, compared with a TTM value of -$5.6 million through Dec 2025, down 108.03%, and an annual FY2025 reading of $31.7 million, down 69.0% over the prior year.
- Equity Average was -$5.6 million for Q4 2025 at Cardlytics, down from $27.0 million in the prior quarter.
- Across five years, Equity Average topped out at $729.6 million in Q2 2021 and bottomed at -$5.6 million in Q4 2025.
- Average Equity Average over 5 years is $323.9 million, with a median of $226.3 million recorded in 2023.
- The sharpest move saw Equity Average surged 442.84% in 2021, then crashed 108.03% in 2025.
- Year by year, Equity Average stood at $689.7 million in 2021, then tumbled by 42.57% to $396.1 million in 2022, then tumbled by 54.54% to $180.1 million in 2023, then crashed by 61.21% to $69.8 million in 2024, then crashed by 108.03% to -$5.6 million in 2025.
- Business Quant data shows Equity Average for CDLX at -$5.6 million in Q4 2025, $27.0 million in Q3 2025, and $61.4 million in Q2 2025.